Alecensaro (alectinib)
pCPA File Number:
20904
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Small Cell Lung Cancer (with CNS metastases)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0092-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: